GlassScriptPhysician profile
Janelle King
NPI 1386879138
$1,800.28
in general payments reported to CMS, 2019-2025
9 companies · $534 in 2025
The $534 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2021: $118 · 2022: $243 · 2023: $111 · 2024: $500 · 2025: $534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,137 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,136.63 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,001.86 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $240.12 | 2024-2025 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $186.98 | 2022-2025 | Libtayo |
| Novartis Pharmaceuticals Corporation | $105.17 | 2024-2025 | |
| Janssen Biotech, INC. | $99.99 | 2019 | |
| Ucb, INC. | $49.06 | 2025 | Bimzelx |
| Galderma Laboratories, L.P. | $46.58 | 2025 | Nemluvio |
| Genzyme Corporation | $39.29 | 2025 | |
| Allergan, INC. | $31.23 | 2019-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janelle King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.